Today, the Chairman of Khiron Life Sciences (KHRNF), Chris Naprawa, bought shares of KHRNF for $7,740.
In addition to Chris Naprawa, 2 other KHRNF executives reported Buy trades in the last month. Following this transaction Chris Naprawa’s holding in the company was increased by 1% to a total of $572.6K.
See today’s analyst top recommended stocks >>
Currently, Khiron Life Sciences has an average volume of 404.16K. The company has a one-year high of $0.90 and a one-year low of $0.22.
The insider sentiment on Khiron Life Sciences has been positive according to 22 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Khiron Life Sciences Corp. engages in the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol and cannabidiol medical cannabis. The company was founded by Álvaro Torres and is headquartered in Toronto, Canada.
